Back to search

Article

Extracellular Matrix-Induced Genes May Reduce Response to Rapamycin in LAM

2024-05-19

Abstract excerpt

<h4>Rationale</h4> Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease driven by nodules containing TSC2 -/- ‘LAM cells’ and recruited LAM associated fibroblasts (LAFs). Although rapamycin reduces lung function loss, some patients continue to decline meaning additional therapies are needed. <h4>Objectives</h4> To investigate how the LAM nodule environment affects LAM cell proliferation and the respons...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1cb7e0f8-f548-517f-95db-c5a909c6185d
DOI
10.1101/2024.05.16.594484
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Extracellular Matrix-Induced Genes May Reduce Response to Rapamycin in LAMDOI 10.1101/2024.05.16.594484
Select a neighboring publication to make it the new centre.